Kyowa Hakko Bio Announces Price Increase for Amino Acids and Derivatives

KHB has abstained from price increases up to now, however the trend is continuing and therefore a price adjustment can no longer be avoided.

7/7/2011 --- Due to a combination of increasing costs for energy, raw materials and logistics as well as the currency exchange rate impact, Kyowa Hakko Bio Co., Ltd has announced that it will increase prices at an average level of 10% with immediate effect for all new contracts. KHB has abstained from price increases up to now, however the trend is continuing and therefore a price adjustment can no longer be avoided.

Kyowa Hakko Bio Co., Ltd. a Japanese company with combined strengths in bio-technologies and chemical synthesis offers an extensive array of innovative high quality products.

It is a pioneer in the development, application and production of fermentation technology and maintains an ongoing commitment to research, developing innovative new products and quality management. Their business is centered on amino acids, vitamins and nucleic acids as well as the derivatives of such for use in pharmaceuticals, nutritional supplements, industrial applications and cosmetics.